Lightbridge (LTBR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Advancing next-generation metallic nuclear fuel technology to improve safety, efficiency, and cost-effectiveness for both existing and next-generation reactors, including small modular reactors, with a focus on clean energy and proliferation resistance.
R&D advanced through collaborations with Idaho National Laboratory, MIT, Texas A&M, and a feasibility study for CANDU reactors in Romania, as well as a completed FEED study with Centrus Energy.
No revenue reported; the company remains in the R&D stage, anticipating commercialization in the 2030s, with initial purchase orders expected 15-20 years from now.
Strategic focus on completing fuel development, achieving regulatory approvals, and establishing commercial partnerships to generate future revenue.
Demand for clean energy from tech companies and international pledges to triple nuclear capacity by 2050 are driving investment in nuclear power.
Financial highlights
Net loss for Q3 2024 was $2.7 million, compared to $1.8 million in Q3 2023; net loss for the nine months ended September 30, 2024, was $7.9 million, up from $5.5 million year-over-year.
Cash and cash equivalents were $26.6 million at September 30, 2024, down from $28.6 million at December 31, 2023.
Working capital was $25.9 million at September 30, 2024, down from $28.3 million at December 31, 2023.
R&D expenses for Q3 2024 were $1.3 million, up from $0.5 million in Q3 2023, and $3.2 million for the nine months ended September 30, 2024, up from $1.3 million year-over-year.
No outstanding debt as of September 30, 2024; operations are financed through equity offerings.
Outlook and guidance
Management projects sufficient cash to fund operations for the next 12 months, with anticipated R&D and G&A expenditures of approximately $14.1 million over that period.
R&D expenses are expected to increase over the next 12-15 months, with a projected $6.8 million investment in nuclear fuel development.
Long-term R&D cash requirements are estimated at $10 million per year for the next 10-15 years; additional funding from government, strategic partners, or equity issuances will be necessary.
Plans to seek additional government funding and strategic alliances to support R&D and commercialization.
Long-term fuel development and commercialization timeline remains consistent with prior disclosures.
Latest events from Lightbridge
- Advanced nuclear fuel technology achieves key milestones and strong financials, targeting global adoption.LTBR
Investor presentation16 Mar 2026 - Fuel development advanced, cash reserves surged, and net loss widened amid strong industry tailwinds.LTBR
Q4 202526 Feb 2026 - Q2 net loss rose to $2.4M as R&D spending increased, with strong cash and regulatory support.LTBR
Q2 20242 Feb 2026 - Advanced nuclear fuel enables safer, more efficient reactors and targets a $16.7B global market.LTBR
Investor presentation15 Jan 2026 - Advanced nuclear fuel nearing commercialization, targeting higher output and safety for global reactors.LTBR
28th Annual Needham Growth Conference Virtual14 Jan 2026 - Lightbridge advanced nuclear fuel tech, expanded R&D, and maintained strong cash reserves.LTBR
Q4 202423 Dec 2025 - Flexible $150M shelf offering to fund advanced nuclear fuel R&D and growth in clean energy.LTBR
Registration Filing16 Dec 2025 - Shareholders will vote on board elections, share authorization, incentive plan expansion, and executive pay.LTBR
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, share increases, incentive plan, pay, and auditor ratification.LTBR
Proxy Filing2 Dec 2025